STOCK TITAN

[144] Axogen, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Axogen, Inc. (AXGN) filed a Form 144 notice reporting a proposed open-market sale of 11,307 common shares with an aggregate market value of $206,316.82. The filing lists the broker as Fidelity Brokerage Services LLC and indicates the shares are to be sold on NASDAQ with an approximate sale date of 10/03/2025. The securities were acquired in two open-market purchases on 08/23/2023 (7,600 shares) and 08/24/2023 (3,707 shares), paid in cash. The filing also discloses a prior sale on 10/02/2025 of 2,400 shares by the Elizabeth J Burke 2024 Irrevocable Trust for gross proceeds of $43,224.00. The filer affirms they are not aware of undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Axogen Inc

NASDAQ:AXGN

AXGN Rankings

AXGN Latest News

AXGN Latest SEC Filings

AXGN Stock Data

1.51B
43.65M
4.79%
87.51%
5.58%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ALACHUA